Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006563 · ClinicalTrials.gov registry record
Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 22
- Enrollment target
NCT02006563 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 22 participants.
The verdict
NCT02006563 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
* Metabolic Tumor Volume (MTV), identified by Magnetic Resonance Spectroscopic Imaging (MRSI) is different from the Clinical Target Volume (CTV) used for radiation dose delivery in the treatment of brain tumors. * If MTV \> CTV, the investigators hypothesize that the difference in volumes (cc) is related to worse clinical outcome. Furthermore, in case of local recurrence, the lesion is located in the MTV area that is outside of the CTV. * Alternatively, if CTV \> MTV, then the difference in volumes is related to higher treatment toxicity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-06-08 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02006563
The ClinicalTrials.gov registry entry for NCT02006563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02006563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02006563 about?
NCT02006563 is a clinical study titled "Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors". * Metabolic Tumor Volume (MTV), identified by Magnetic Resonance Spectroscopic Imaging (MRSI) is different from the Clinical Target Volume (CTV) used for radiation dose delivery in the treatment of brain tumors. * If MTV \> CTV, the investigators hypothesize that the difference in volumes (cc) is re...
What is the current status of trial NCT02006563?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-06-08. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02006563?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.